Syntho Pharmaceuticals Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 230 Sherwood Ave., Farmingdale, New York (NY) 11735, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 3003407422 · DUNS 088797407
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2019-09-03
- OAIDrug Quality Assurance2017-03-09
- OAIDrug Quality Assurance2016-08-26
- OAIDrug Quality Assurance2013-08-23
- OAIDrug Quality Assurance2012-02-21
- OAIDrug Quality Assurance2011-11-28
- OAIUnapproved and Misbranded Drugs2011-11-28
- VAIDrug Quality Assurance2010-11-08
- NAIDrug Quality Assurance2010-04-28
- OAIDrug Quality Assurance2009-02-03
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- Esterified Estrogens, MethyltestosteroneLeading Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.